Cybersecurity Requirements for 510(k): Documents, Risk & Tips

Cybersecurity requirements for 510(k) focus on ensuring that medical devices with software or connectivity can withstand cyber threats. 510(k) cybersecurity requirements mandate detailed documentation of secure design, risk management, and postmarket controls for “cyber devices.” Notably, manufacturers are required to demonstrate cybersecurity safeguards in their 510(k) filings.

What is FDA 510(k)?

The FDA 510(k) submission is a premarket notification process that medical device manufacturers must follow to demonstrate that their device is “substantially equivalent” to a legally marketed device (called a predicate) in terms of safety and effectiveness. FDA 510(k) helps manufacturers do away with the need for full clinical trials as required in a Premarket Approval. The 510(k) pathway allows companies to show that their new device has the same intended use and similar technological characteristics as an existing device. Moreover, any differences, if present, should not raise new safety or effectiveness concerns. This streamlined process is the most common route for medical devices entering the U.S. market. It helps ensure patient safety while supporting innovation and faster market access.

What are cyber devices?

A “cyber device” under FDA law is any medical device that contains software, can connect to the internet, and has technological features that could be vulnerable to cybersecurity threats. These devices include those with firmware, programmable logic, or cloud-based components. As they are exposed to potential cyber threats, manufacturers must address cybersecurity in their regulatory submissions. As per cybersecurity requirements for 510(k), manufacturers are required to provide Software Bill of Materials (SBOM). It should document risk assessments and threat models as well as outline patching and vulnerability management plans to ensure patient safety and device reliability. We have presented the key elements of a cyber device:

• Software base: Includes software, firmware, or programmable logic validated, installed, or authorized by the manufacturer.
• Internet connectivity: Has the ability to connect to the internet directly or indirectly.
• Cybersecurity vulnerability: Contains technological characteristics that could be exploited by cyber threats.

What are cybersecurity requirements for 510(k)?

Cybersecurity requirements for 510(k)focus on ensuring that medical devices with software or connectivity are designed, tested, and documented to withstand cyber threats. Manufacturers must demonstrate that they have identified potential vulnerabilities and implemented safeguards, such as authentication, encryption, and access controls. Additionally, they should have established processes for timely updates and patches. A Software Bill of Materials (SBOM) is expected to provide transparency about third-party components. Moreover, risk analyses and penetration testing evidence are required to show proactive risk management. Additionally, FDA requires a plan for postmarket monitoring and coordinated vulnerability disclosure. Thus, cybersecurity is an integral part of overall device safety and effectiveness in the 510(k) review process.

1. Scope

Cybersecurity requirements for 510(k) apply to medical devices that include software, firmware, or programmable logic. These devices often have internet connectivity or features that make them vulnerable to cyber threats. The rules cover all types of 510(k) submissions: traditional, special, and abbreviated. This ensures that even minor modifications or updates to devices are reviewed for cybersecurity risks. Thus, any connected or software-driven device must demonstrate resilience against cyber vulnerabilities.

2. Regulations for cyber devices

Manufacturers must identify cybersecurity risks and provide mitigation strategies in their submissions. They are required to submit a Software Bill of Materials (SBOM) for transparency about third-party components. A plan for updates and patches must be included to address vulnerabilities postmarket. Additionally, manufacturers must ensure monitoring and coordinated vulnerability disclosure processes are in place.

3. Secure product development framework (SPDF)

FDA recommends adopting a Secure Product Development Framework (SPDF) to integrate cybersecurity throughout the device lifecycle. This involves conducting threat modeling during design to anticipate potential attack vectors. Moreover, security risk assessments should align with ISO 14971 principles for medical device risk management. Devices must incorporate safeguards, such as authentication, encryption, and access controls. Logging and monitoring features should also be built in to detect and respond to incidents quickly.

Documentation expectations under cybersecurity requirements for 510(k)

1. Design controls: Manufacturers must show how cybersecurity has been integrated into their Quality Management System (QMS). This includes evidence that secure design practices were followed throughout development.
2. Risk analysis reports: Submissions should include detailed risk analyses identifying potential vulnerabilities. Each risk must be paired with mitigation strategies to demonstrate proactive management.
3. Testing evidence: FDA expects proof of security testing, such as penetration testing, static code analysis, and dynamic code analysis. These results validate that the device can withstand real-world cyber threats.
4. Update and patch management plan: Manufacturers must outline clear procedures for issuing timely updates and patches. This ensures vulnerabilities can be addressed quickly after the device is on the market.
5. User instructions: The FDA 510(k) submission should provide guidance for end-users on secure configuration and maintenance. Clear labeling helps healthcare providers and patients operate the device safely.

Risks and challenges for 510(k) cybersecurity compliance

• Non-compliance: Failure to meet cybersecurity requirements for 510(k) can result in FDA rejecting or delaying the 510(k) submission. This not only stalls market entry but also increases regulatory scrutiny in future filings. Companies risk reputational damage if their devices are perceived as unsafe or insecure.
• Incomplete SBOMs: Submitting an incomplete or vague Software Bill of Materials (SBOM) is a common pitfall. Without full transparency of third-party and open-source components, vulnerabilities may remain hidden. FDA reviewers often flag such gaps, thereby leading to requests for additional information.
• Global harmonization issues: Different regions, such as the EU MDR and Health Canada, have similar but not identical cybersecurity expectations. This creates complexity for manufacturers seeking multi-market approvals. Aligning documentation across jurisdictions requires extra effort and resources.
• Audit pressure: FDA reviewers now scrutinize cybersecurity as part of overall device safety. This increases the burden on manufacturers to provide detailed evidence of secure design and testing. Audit findings can lead to corrective actions, thereby delaying clearance and impacting business timelines.
• Postmarket challenges: Cybersecurity risks do not end at clearance. Devices must be monitored continuously. Manufacturers must maintain patching and vulnerability disclosure processes to stay compliant. Notably, failure to act quickly on emerging threats can trigger recalls or enforcement actions.

5 Actionable steps for manufacturers to comply with cybersecurity requirements for 510(k)

1. Integrate cybersecurity early in design: Manufacturers should embed cybersecurity considerations at the earliest stages of product development. This ensures that security is not treated as an afterthought but as a core safety feature. Early integration reduces costly redesigns and strengthens FDA submission readiness.
2. Develop a robust SBOM: A complete Software Bill of Materials (SBOM) must list all third-party, open-source, and commercial components. This transparency helps identify vulnerabilities quickly and supports patch management. An incomplete SBOM is a common reason for FDA requests for additional information.
3. Align with ISO 14971 & IEC 81001-5-1: Risk management should follow ISO 14971 principles, while IEC 81001-5-1 provides specific guidance for health software security. Aligning with these standards demonstrates compliance with internationally recognized frameworks. It also reassures regulators that cybersecurity risks are systematically managed.
4. Prepare a vulnerability disclosure policy: Manufacturers must establish a clear process for reporting and addressing vulnerabilities. This includes coordinated disclosure with healthcare providers and security researchers. A transparent policy builds trust and ensures timely mitigation of emerging threats.
5. Document patch and update procedures: FDA expects a clear plan for issuing patches and updates to address vulnerabilities postmarket. This should include timelines, delivery mechanisms, and communication strategies for users. Well-documented procedures show regulators that the device will remain secure throughout its lifecycle.

In this blog, we have detailed the cybersecurity requirements for 510(k) submission. Drop an email at [email protected] or call/Whatsapp on 9996859227 for assistance with US FDA 510(k) submission. Our team has extensive experience in US FDA regulations for medical devices.